Akari Therapeutics Plc
AKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001541157
No open-market purchases or sales by Akari Therapeutics Plc insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.54M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Akari Therapeutics Plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Akari Therapeutics Plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Farag Kameel D. | Interim CFO | 23,309 | Aug 19, 2026 | 6 |
| Patel Samir Rashmikant | Director, 10% Owner | 98,241Indirect | Jul 17, 2026 | 2 |
| Gaslightwala Abizer | CEO | 298,574 | Jun 25, 2026 | 2 |
| Neal James R | Director | 36,271 | Mar 16, 2026 | 1 |
| Prudo-Chlebosz Raymond | Director | 2,484,990 | Dec 18, 2025 | 1 |
| Patel Sandip I | Director | 496,499 | Dec 18, 2025 | 1 |
| Huh Hoyoung | Director, 10% Owner | 4,695,854 | Dec 18, 2025 | 1 |
| Bazemore Robert B | Director | 44,642 | Dec 18, 2025 | 1 |
| Hombeck Torsten | CFO | 200 | Mar 24, 2025 | 0 |
| Williams Donald A | Director | – | Jul 2, 2024 | 0 |
| Grissinger Michael | Director | – | Jul 2, 2024 | 0 |
| Hashad Mohamed Wa'el Ahmed | Director | – | Jul 2, 2024 | 0 |
| Dicicco Wendy F | Interim CFO | 158,473,915 | May 3, 2024 | 0 |
| Jacques Rachelle Suzanne | Chief Executive Officer | 1,018,027,792 | Apr 30, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 (view filing)5:00 PM ET | Dec 16, 2025 | 90 daysLate | Neal James RDirector | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +11.1K | $0.4041 | +$2.25K | –3.09K after | Derivative4 lots |
| Dec 18, 2025 (view filing)9:58 PM ET | Dec 16 | 2 days | Prudo-Chlebosz RaymondDirector | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +2.01M | $0.4041 | +$406.2K | –386.7K after | Derivative4 lots |
| Dec 18, 2025 (view filing)9:57 PM ET | Dec 16 | 2 days | Patel Sandip IDirector | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +804.3K | $0.4041 | +$162.5K | –154.7K after | Derivative4 lots |
| Dec 18, 2025 (view filing)9:57 PM ET | Dec 16 | 2 days | Huh HoyoungDirector, 10% Owner | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +7.42M | $0.4041 | +$1.50M | –3.09M after | Derivative4 lots |
| Dec 18, 2025 (view filing)9:57 PM ET | Dec 16 | 2 days | Farag Kameel D.Interim CFO | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +49.5K | $0.4041 | +$10.0K | –24.7K after | Derivative2 lots |
| Dec 18, 2025 (view filing)9:56 PM ET | Dec 16 | 2 days | Patel Samir RashmikantDirector, 10% Owner | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +1.24M | $0.4041 | +$250.0K | –618.7K after | Derivative2 lots |
| Dec 18, 2025 (view filing)9:56 PM ET | Dec 16 | 2 days | Patel Samir RashmikantDirector, 10% Owner | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +464.0K | $0.4041 | +$93.7K | –232.0K after | Derivative2 lots |
| Dec 18, 2025 (view filing)9:56 PM ET | Dec 16 | 2 days | Gaslightwala AbizerCEO | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +2.17M | $0.4041 | +$437.5K | –773.3K after | Derivative4 lots |
| Dec 18, 2025 (view filing)9:56 PM ET | Dec 16 | 2 days | Bazemore Robert BDirector | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +309.3K | $0.4041 | +$62.5K | –30.9K after | Derivative4 lots |
| Aug 29, 2025 (view filing) | Aug 21-25 | 8 daysLate | Gaslightwala AbizerCEO | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +21.0K | $0.9305 | +$19.5K | +7.6%298.6K after | 3 lots |
| Jun 25, 2025 (view filing) | Jun 23-24 | 2 days | Gaslightwala AbizerPresident & CEO | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +6.15K | $1.16 | +$7.12K | +2.3%277.6K after | 2 lots |
| Jun 24, 2025 (view filing) | Jun 20 | 4 days | Gaslightwala AbizerPresident & CEO | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +10.0K | $1.20 | +$12.0K | +3.8%271.4K after | |
| Jun 20, 2025 (view filing) | Jun 17 | 3 days | Gaslightwala AbizerPresident & CEO | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +15.0K | $1.20 | +$18.0K | +6.1%261.4K after |